Rapidly increasing maternal morbidity and death continue to be mostly attributed to cardiovascular disease. Whenever both the pregnant woman and the developing foetus are exposed to several possible difficulties, various physiological changes of gestation happen. Women who have pre-existing cardiac conditions, such as congenital abnormalities, angina pectoris, coronary artery disease and aortopathies, need to undergo multidisciplinary testing, counselling, and optimization before getting pregnant. They also need to be closely monitored and have their medication needs managed. Close monitoring is crucial for patients who developed cardiac conditions like congestive heart failure, preeclampsia, cardiomyopathy, coronary events, or arrhythmia while pregnant. The signs of a cardiac issue during pregnancy include- fatigue, chest pain, shortness of breath, fainting, difficulty breathing while sleeping.
Title : Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI
Michael E Merhige, State University of NY at Buffalo, United States
Title : Effects of impaired microcirculation in the musculoskeletal system
Roger H Coletti, Interventional Health, PA, United States
Title : Cardio nanomedicine: Fighting plaque, opening arteries, and healing hearts
Thomas J Webster, Hebei University of Technology, China
Title : Dopamine D2 receptor and inverse salt sensitivity
Pedro A Jose, The George Washington University of School of Medicine & Health Sciences, United States
Title : Clinical pharmacology of sotagliflozin – Novel quality in treatment of heart failure
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Rationale for the prevention or therapy of sudden cardiac death in heart failure
Naranjan Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada